1119451-14-7

Basic information

• Product Name: 2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid
• Synonyms: 2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid
• CAS NO: 1119451-14-7
• Molecular Formula: C20H19NO5
• Molecular Weight: 353.36856
• Mol File: 1119451-14-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid(1119451-14-7)
• EPA Substance Registry System: 2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid(1119451-14-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1119451-14-7(Hazardous Substances Data)

Usage

General Description

2,3-dimethoxy-8-oxo-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-13-carboxylic acid is a complex chemical compound with a molecular structure containing methoxy and carboxylic acid functional groups. It belongs to the family of isoquinoline compounds and has a 13-carboxylic acid group. This chemical is used in the field of organic chemistry for research purposes, and its structure and properties make it potentially useful in pharmaceutical applications. Its intricate structure and functional groups provide opportunities for further study and potential applications in drug development and other areas of chemical research.

Upstream product

• 3382-18-1 6,7-dimethoxy-3,4-dihydro-isoquinoline 
• 703-59-3 homophthalic anhydride 
• 1095271-32-1 (13R,13aR)-2,3-dimethoxy-8-oxo-5,6,7,13,13a-pentahydroisoquinolino[2,1-b]isoquinoline-13-carboxylic acid 

Downstream Products

• 1095271-33-2 (13S,13aR)-2,3-dimethoxy-8-oxo-5,6,7,13,13a-pentahydroisoquinolino[2,1-b]isoquinoline-13-carboxylic acid 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NASH, NAFLD, AND OBESITY

The present technology relates to methods of treating NASH, NAFLD and/or obesity using compounds of Formulas I, II, III, IV, V, and/or VI. The methods include administering to a subject suffering from one or more of non-alcoholic steatohepatitis (NASH), non- alcoholic fatty liver disease (NAFLD) and/or obesity a therapeutically effective amount of such a compound

COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING LIPID LEVELS

Compositions comprising extracts or isolated or purified compounds from plants of the genus Corydalis provide prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. Corydalis compounds and their derivatives of natural and synthetic origins lower total cholesterol, LDL-cholesterol, and triglycerides and increase hepatic LDL receptor expression and activate AMP-activated protein kinase. Specific stereoisomers of Corydalis compounds with lipid lowering activity include 14R-(+)-corypalmine, 14R,13S-(+)-corydaline, 14R-(+)-tetrahydropalmatin, (+)-corlumidin, d-(+)-bicuculline, and (+)-egenine.